Literature DB >> 25307174

Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn's disease.

Y Li1, W Zhu, J Gong, W Zhang, L Gu, Z Guo, L Cao, B Shen, N Li, J Li.   

Abstract

AIM: Mesenteric hypertrophy has been recognized as an indicator of the complicated course of Crohn's disease. The aim of this study was to investigate whether the visceral fat area (VFA) is associated with postoperative clinical and endoscopic recurrence.
METHOD: Computed tomography was used to measure the subcutaneous fat area and VFA, and the mesenteric fat index (MFI) was defined as the ratio of the VFA to the subcutaneous fat area. Associations between body mass index, subcutaneous fat area, VFA and MFI and postoperative clinical and endoscopic recurrence were investigated.
RESULTS: The factors associated with postoperative endoscopic recurrence at 6 months after surgery were a high VFA value (P = 0.019) and MFI values above the median (P = 0.008). VFA values were significantly correlated with endoscopic recurrence (r = 0.895, P = 0.040) and endoscopic lesions (r = 0.617, P < 0.0001). Additionally, MFI values correlated well with endoscopic recurrence (r = 0.918, P = 0.02) and endoscopic scores (r = 0.584, P < 0.0001). Multivariate analysis indicated that VFA values above the median (hazard ratio 2.63, 95% CI 1.03-6.74) were predictive of postoperative clinical recurrence in Crohn's disease.
CONCLUSION: A high VFA value is associated with postoperative recurrence of Crohn's disease and has clinical implications with respect to optimizing prophylaxis for each individual. However, further studies are needed to confirm the predictive role of this biomarker in a different data set. Colorectal Disease
© 2014 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Crohn's disease; mesenteric adipose tissue; recurrence; risk factor; visceral fat

Mesh:

Substances:

Year:  2015        PMID: 25307174     DOI: 10.1111/codi.12798

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  24 in total

Review 1.  Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes.

Authors:  Siddharth Singh; Parambir S Dulai; Amir Zarrinpar; Sonia Ramamoorthy; William J Sandborn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-30       Impact factor: 46.802

2.  Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease.

Authors:  Kimberley W J Van Der Sloot; Amit D Joshi; Danielle R Bellavance; Katherine K Gilpin; Kathleen O Stewart; Paul Lochhead; John J Garber; Cosmas Giallourakis; Vijay Yajnik; Ashwin N Ananthakrishnan; Behrooz Z Alizadeh; Ramnik J Xavier; Hamed Khalili
Journal:  Inflamm Bowel Dis       Date:  2017-01       Impact factor: 5.325

Review 3.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

4.  The relationship between perianal fistula activity and abdominal adipose tissue in Crohn's disease: an observational study.

Authors:  Ziman Xiong; Ziling Zhou; Luwen Hao; Yuanqiu Li; Xuemei Hu; Daoyu Hu; Yan Luo; Yanchun Wang; Yaqi Shen; Zhen Li
Journal:  Insights Imaging       Date:  2022-09-24

Review 5.  Obesity, a challenge in the management of inflammatory bowel diseases.

Authors:  Mohsen Rajabnia; Shideh Moftakhari Hajimirzaei; Mohammad Reza Hatamnejad; Shabnam Shahrokh; Shaghayegh Baradaran Ghavami; Maryam Farmani; Naghmeh Salarieh; Nastaran Ebrahimi; Nesa Kazemifard; Azam Farahanie; Ghazal Sherkat; Hamid Asadzadeh Aghdaei
Journal:  Immunol Res       Date:  2022-08-29       Impact factor: 4.505

Review 6.  Management of Inflammatory Bowel Diseases in Special Populations: Obese, Old, or Obstetric.

Authors:  Siddharth Singh; Sherman Picardo; Cynthia H Seow
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-08       Impact factor: 11.382

7.  Mesenteric Lymphatic Vessel Density Is Associated with Disease Behavior and Postoperative Recurrence in Crohn's Disease.

Authors:  Yi Li; Yuanyuan Ge; Jianfeng Gong; Weiming Zhu; Lei Cao; Zhen Guo; Lili Gu; Jieshou Li
Journal:  J Gastrointest Surg       Date:  2018-07-24       Impact factor: 3.452

8.  Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohn's disease.

Authors:  Ren Mao; Genevieve Doyon; Ilyssa O Gordon; Jiannan Li; Sinan Lin; Jie Wang; Thi Hong Nga Le; Michael Elias; Satya Kurada; Brian Southern; Mitchell Olman; Minhu Chen; Shuai Zhao; Dina Dejanovic; Jyotsna Chandra; Pranab K Mukherjee; Gail West; David R Van Wagoner; Claudio Fiocchi; Florian Rieder
Journal:  Gut       Date:  2021-01-19       Impact factor: 31.793

Review 9.  Optimal delivery of follow-up care after surgery for Crohn's disease: current perspectives.

Authors:  James P Campbell; Byron P Vaughn
Journal:  Clin Exp Gastroenterol       Date:  2016-08-08

Review 10.  Interaction of obesity and inflammatory bowel disease.

Authors:  Jason W Harper; Timothy L Zisman
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.